Menu
PacPremier
Magic Hour
Montecito
SoCal Gas
Loading...
You are here:  Home  >  'Amgen'  -  Page 66
Latest

PBS Biotech acquires manufacturing firm

By   /  Friday, August 26th, 2011  /  Technology, Top Stories  /  Comments Off on PBS Biotech acquires manufacturing firm

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen expects approval for Xgeva as bone treatment in April

By   /  Monday, August 22nd, 2011  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen expects approval for Xgeva as bone treatment in April

Thousand Oaks-based Amgen said Aug. 22 that the U.S. Food and Drug Administration will likely make a decision by April 26, 2012 on the biotech firm’s application to expand the use of its Xgeva bone treatment drug to treat advanced prostate cancer. Amgen, the largest biotech company in the world, said in a statement that Read More →

Read More →
Latest

Brave new biotech: Camarillo startup launches first products

By   /  Friday, May 27th, 2011  /  Features, Technology  /  Comments Off on Brave new biotech: Camarillo startup launches first products

PBS Biotech, a Camarillo-based startup, is bringing its first products to market.

Read More →
Latest

Amgen drug shows blockbuster promise

By   /  Friday, May 20th, 2011  /  Technology, Top Stories  /  Comments Off on Amgen drug shows blockbuster promise

Putting test results behind the talk at its recent product pipeline review, Thousand Oaks-based Amgen on May 17 released promising results for the Xgeva variant of its potential blockbuster bone drug denosumab.

Read More →
Latest

Beyond biologics: Amgen bets new drugs will pay dividend

By   /  Friday, May 6th, 2011  /  Banking & Finance, Features, Tri-County Public Companies  /  Comments Off on Beyond biologics: Amgen bets new drugs will pay dividend

Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.

Read More →
Latest

Amgen gets sought-after FDA approval

By   /  Thursday, November 18th, 2010  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen gets sought-after FDA approval

The Food and Drug Administration has approved the use of Amgen’s bone drug denosumab in patients with certain types of cancer, Amgen announced Nov. 18.

Read More →
Latest

Amgen reports earnings drop

By   /  Monday, October 25th, 2010  /  Earnings, Technology, Tri-County Public Companies  /  Comments Off on Amgen reports earnings drop

Thousand Oaks-based Amgen said Oct. 25 that third-quarter earnings fell 14 percent to $1.3 billion as revenue flatlined. Amgen is the world’s biggest biotech company and the largest private employer in the Tri-Counties. It reported adjusted earnings per share of $1.36, a decrease of 9 percent compared to the same quarter last year. Total revenue Read More →

Read More →